Sign in
4

Changes in Ownership

Clene Inc. Filed Acc 0001562180-22-001501

Options or other derivatives

  • Chief Medical Officer acquired 140,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Glanzman Robert Chief Medical Officer 2022-02-15 Grant or award · Stock Options (Right to buy) +140,000 140,000 D
Loading xslF345X03/primarydocument.xml…